American Vanguard launches B Sure liquid biostimulant to boost crop productivity and resilience
American Vanguard has introduced B Sure, a new liquid biostimulant aimed at enhancing plant development and improving crop resilience to stress. This product is compatible with a variety of crops and is designed to increase overall productivity, meeting the growing demand for sustainable agricultural solutions. The company expects B Sure to help farmers achieve stronger and more robust plant growth.
AVD Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial analysis of American Vanguard Corp (AVD), detailing its revenue breakdown, profitability margins, and a comparison with competitors. AVD generates most of its revenue from herbicides/soil fumigants/fungicides, accounting for 50.7% of total sales. The company's financial health is examined through its gross margin (26.32%), operating margin (5.28%), net margin (-18.72%), and Return on Equity (-23.45%), with a competitive benchmark against FNUC and BIOX.
Vanguard disaggregates holdings; reports 0 shares of American Vanguard Corp (AVD)
The Vanguard Group has amended its Schedule 13G filing for American Vanguard Corp (AVD), reporting 0 shares beneficially owned as a result of an internal realignment on January 12, 2026. This change disaggregates holdings, with subsidiaries now reporting separately. The filing indicates this is an administrative change, not a sale of shares, and cash-flow treatment or holdings by other Vanguard entities are not detailed.
American Vanguard Corp stock faces regulatory headwinds amid chemical sector volatility and environm
American Vanguard Corp (ISIN: US03027X1000) is navigating significant challenges in the agricultural chemical sector due to tightening environmental regulations and fluctuating market dynamics. As a specialty chemical company, it focuses on crop protection and pest control products, balancing innovation with sustainability demands. The stock's performance is influenced by broader industry pressures, feedstock volatility, and the need to adapt to integrated pest management trends, with no major new catalysts reported recently.
American Vanguard Corporation share price
This article provides details on American Vanguard Corporation (AVD) stock, including its current price ($2.33 as of March 24, 2026), 52-week high and low, key financial metrics like market cap and revenue, and historical returns. It also offers brief information on how to invest in US stocks and answers frequently asked questions about the company.
American Vanguard Raises $285 Million in New First- and Second-Lien Term Loans, Retires Prior Facility
American Vanguard, through its subsidiary AMVAC, successfully completed a $285 million refinancing on March 13, 2026. This involved securing new first-lien and second-lien term loans and retiring its previous 2021 credit agreement. The company expects this new financial structure to enhance liquidity and better align with its current operating needs.
American Vanguard (NYSE: AVD) adds $285M first- and second-lien debt
American Vanguard Corporation (NYSE: AVD), through its subsidiary AMVAC Chemical, has secured new first- and second-lien term loans totaling $285 million. These loans, consisting of a $225 million first-lien facility and a $60 million second-lien facility, will be used to refinance existing debt and provide approximately $68.5 million for general corporate and working capital purposes. The new financing comes with specific interest rates, maturity dates, and governance provisions, including board size reduction and independent director approval for certain actions.
American Vanguard Reports FY2025: $515.1M Sales, $39.2M Adjusted EBITDA, $49.9M Net Loss
American Vanguard (AVD) reported its full-year 2025 financial results, with net sales reaching $515.1 million and adjusted EBITDA at $39.2 million. The company's GAAP net loss significantly narrowed to $49.9 million from $126.3 million in 2024, attributed to improved gross margin and reduced operating costs. Key business highlights include securing $285 million in new term loans, rationalizing a manufacturing facility, and planning a corporate headquarters relocation for efficiency and savings.
American Vanguard (NYSE: AVD) trims 2025 loss, guides higher EBITDA on cost cuts
American Vanguard reported a narrower net loss in 2025 due to improved gross margins and cost controls, despite a 6% decline in net sales. The company provided optimistic guidance for 2026, projecting higher Adjusted EBITDA and sales, driven by facility rationalization, headquarters relocation, and new product launches aimed at generating significant future revenue. They also successfully remediated all material weaknesses identified in the 2024 audit and refinanced their credit facility.
American Vanguard Reports Full Year 2025 Results
American Vanguard Corporation announced its financial results for the full year 2025, reporting a decline in net sales but an increase in adjusted EBITDA. The company extended and expanded its credit capacity with two new term loan agreements totaling $285 million and plans to rationalize its Los Angeles manufacturing facility to improve efficiency. American Vanguard forecasts adjusted EBITDA of $44-$48 million in 2026, signaling efforts to strengthen its capital structure and improve operational efficiency amidst a recovering agricultural market.
Earnings call transcript: American Vanguard’s Q4 2025 revenue misses target
American Vanguard Corporation reported a 6% revenue decline in 2025, reaching $515 million, below its target. CEO Douglas Kaye highlighted initiatives like rationalizing manufacturing, new product development, and cost reduction to improve future profitability and reduce debt. The company projects adjusted EBITDA of $44 million-$48 million on sales of $530 million-$550 million for 2026, aiming for a long-term EBITDA margin of 15%.
American Vanguard: Fourth Quarter Earnings Overview
American Vanguard Corp. reported a net loss of $28.2 million, or 99 cents per share, for the fourth quarter, with adjusted earnings of 6 cents per share. The agricultural products firm generated $150.7 million in revenue during this period. For the full year, the company's net loss was $49.9 million, or $1.75 per share, on revenues of $515.1 million.
American Vanguard: Q4 Earnings Snapshot
American Vanguard Corp. (AVD) reported a significant net loss of $28.2 million, or 99 cents per share, in its fourth quarter, though adjusted earnings reached 6 cents per share. The agricultural products company posted revenue of $150.7 million for the quarter. For the full year, the company's loss narrowed to $49.9 million on revenue of $515.1 million.
American Vanguard (NYSE:AVD) Posts Quarterly Earnings Results, Misses Estimates By $0.22 EPS
American Vanguard (NYSE:AVD) reported quarterly earnings of $0.06 per share, significantly missing analysts' consensus estimate of $0.28 per share by $0.22. The basic materials company also reported revenue of $150.69 million, falling short of the estimated $163.00 million. Despite these misses, the company highlighted recent debt refinancing, operational rationalization expected to save millions annually, and a projected product-driven growth runway with ambitious revenue targets for 2030-31.
American Vanguard Q4 Loss: $28.2M, Revenue $150.7M | 2026 Report - News and Statistics
American Vanguard Corp. reported a net loss of $28.2 million, or 99 cents per share, for the final quarter of its fiscal year, with quarterly revenue reaching $150.7 million. Adjusted earnings were 6 cents per share. For the full year, the company's financial loss was $49.9 million, or $1.75 per share, on annual revenue of $515.1 million, and its share price closed at $4.07 on the day of the report, lower than the previous year.
American Vanguard: Q4 Earnings Snapshot
American Vanguard Corp. (AVD) reported a Q4 loss of $28.2 million, or 99 cents per share, with adjusted earnings of 6 cents per share. The company's revenue for the quarter was $150.7 million, while its full-year loss narrowed to $49.9 million on $515.1 million in revenue. Shares were trading at $4.07, down from $4.43 a year prior.
American Vanguard: Fourth Quarter Earnings Overview
American Vanguard Corp. reported a net loss of $28.2 million for the fourth quarter, or 99 cents per share, though adjusted earnings were 6 cents per share. The company generated $150.7 million in revenue for the quarter. For the full year, the net loss totaled $49.9 million with annual revenue reaching $515.1 million.
American Vanguard 2025 10-K: $515.1M Revenue, $(1.75) EPS
American Vanguard reported net sales of $515.1 million for 2025, a 6% decrease from 2024, resulting in a net loss of $49.9 million or $(1.75) per share. Despite the decline in revenue, the company improved its gross profit and narrowed its operating loss, highlighting recovery in margins due to eased cost pressures and operational restructuring.
Earnings call transcript: American Vanguard’s Q4 2025 revenue misses target
American Vanguard reported a 6% decline in revenue for 2025, reaching $515 million, which fell short of its target range. Despite missing revenue, the company improved its gross profit margin to 29% and is implementing cost-cutting measures, including closing its Los Angeles manufacturing facility and relocating its headquarters. For 2026, American Vanguard forecasts sales between $530 million and $550 million, with a focus on new product launches and operational efficiencies to drive future growth and profitability.
American Vanguard Corporation (AVD) Stock Falls on Q4 2025 Earnings
American Vanguard Corporation (AVD) reported fourth-quarter 2025 earnings showing a significant decline in revenue and net income, missing analyst estimates. Total revenues dropped 9.0% year-over-year to $150.7 million, with a net loss of -$28.2 million. The stock reacted negatively, falling 1.68% since market close.
American Vanguard: Q4 Earnings Snapshot
American Vanguard Corp. (AVD) reported a Q4 loss of $28.2 million, or 99 cents per share, with adjusted earnings of 6 cents per share. The company's revenue for the quarter was $150.7 million. For the full year, American Vanguard's loss narrowed to $49.9 million on revenues of $515.1 million.
American Vanguard (AVD) Quarterly Loss Deepens Margin Concerns And Challenges Profitability Narrative
American Vanguard (AVD) reported mixed Q3 FY 2025 results with deepened losses, impacting its profitability narrative. Despite some analyst optimism about margin expansion and growth, the company's trailing twelve-month figures show significant losses and poor debt coverage. The market reflects this concern with a low P/S ratio, highlighting a disconnect between growth projections and current financial performance.
American Vanguard Corporation (AVD) Stock Falls on Q4 2025 Earnings
American Vanguard Corporation (AVD) reported a significant decline in its Q4 2025 earnings, with revenues down 9.0% year-over-year to $150.7 million and a net loss of -$28.2 million. The diluted EPS also fell substantially to -$0.99. Both revenue and EPS missed analyst estimates, causing the stock to drop by 1.68% since market close.
American Vanguard Announces Date of Full Year 2025 Earnings Release and Webcast Conference Call
American Vanguard Corporation announced that it will release its full-year 2025 financial results on Monday, March 16, 2026, after the market closes. The company will also host an earnings conference call and webcast on the same day at 4:30 pm ET, led by CEO Dak Kaye and CFO David T. Johnson. The webcast will be available on the company's website and archived for one year.
AVD SEC Filings - American Vanguard Corp 10-K, 10-Q, 8-K Forms
This page provides access to American Vanguard Corp (AVD) SEC filings, including annual 10-K reports, quarterly 10-Q earnings, and 8-K material event forms, with AI-powered summaries to help investors. It details the company's financial performance, operational developments, and governance disclosures. Recent Q2-25 filings show a narrowed loss despite tightened credit terms, highlighting the company's efforts to manage debt and operational costs.
American Vanguard (AVD) Expected to Announce Earnings on Wednesday
American Vanguard (AVD) is scheduled to release its Q4 2025 earnings before market open on Wednesday, March 11th. Analysts project earnings per share of $0.28 and revenue of $163.0 million. The basic materials company has seen high institutional ownership and a "Hold" consensus rating from Wall Street, with a target price of $12.00.
Short Interest in American Vanguard Corporation (NYSE:AVD) Declines By 28.2%
Short interest in American Vanguard Corporation (NYSE:AVD) decreased by 28.2% in February, falling to 662,079 shares, which represents about 2.5% of the stock. With an average daily trading volume, the days-to-cover ratio is 3.9 days. Analysts have mixed views, with a consensus "Hold" rating and a target price of $12.00, while institutional investors hold 79.00% of the company's stock.
American Vanguard (NYSE:AVD) Stock Crosses Above 200-Day Moving Average - Should You Sell?
American Vanguard (NYSE:AVD) briefly traded above its 200-day moving average of $4.87 on Thursday but closed down approximately 3.9% at $4.72. Analyst sentiment for AVD is mixed, with ratings ranging from "hold" to "sell" and an average price target of $12.00. The company is a small-cap entity specializing in specialty chemical products, with significant institutional ownership and a debt-to-equity ratio of 0.82.
American Vanguard (NYSE:AVD) Stock Price Crosses Above 200-Day Moving Average - Time to Sell?
American Vanguard (NYSE:AVD) stock recently crossed above its 200-day moving average, trading as high as $5.35 before settling at $5.2440. Despite this, analyst sentiment remains mixed, with a consensus "Hold" rating and a target price of $12.00, alongside some "Sell" and "Hold" recommendations. The company has a market capitalization of $149.3 million, a negative P/E ratio, and significant institutional ownership.
American Vanguard to Relocate to Irvine Co.’s Discovery Park
American Vanguard Corp. is moving its corporate headquarters from Newport Beach to Irvine Company’s Discovery Park in Irvine, a strategic relocation aimed at reducing costs and improving efficiency. The pesticide and agricultural products manufacturer expects the move to be completed by the end of the second quarter of 2026. This decision follows recent leadership changes and is part of a broader initiative to streamline operations and optimize the company's real estate footprint.
Essex Investment Management Co. LLC Purchases Shares of 372,064 American Vanguard Corporation $AVD
Essex Investment Management Co. LLC has acquired a new stake of 372,064 shares in American Vanguard Corporation (NYSE:AVD) during the third quarter, valued at approximately $2.14 million. This purchase contributes to institutional and hedge funds collectively owning about 79% of the company. Despite these institutional investments, analyst sentiment for American Vanguard is mixed, with a consensus "Hold" rating and an average price target of $12.00, although the company is currently operating at a loss.
American Vanguard (NYSE:AVD) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened
American Vanguard (NYSE:AVD) stock recently crossed above its 200-day moving average, trading as high as $5.39. Despite this, analysts have a "Hold" rating with an average target price of $12.00, reflecting mixed sentiment. The company reported a quarterly earnings miss and remains unprofitable, with institutional investors showing varying levels of activity in their holdings.
The Truth About American Vanguard Corp: Is This Sleeper Stock About To Explode Or Fade Out?
American Vanguard Corp (AVD) is presented as a potentially undervalued small-cap stock in the agriculture, chemicals, and environmental protection sectors, often overlooked by mainstream investors. The article explores whether AVD represents a shrewd long-term investment due to its essential business in a stable industry or if its lack of viral hype makes it a risky bet. It advises investors to consider the company's niche market, stock volatility, and value proposition in the context of agricultural macro trends and regulations.
American Vanguard Stock Tries To Find Its Footing As Investors Weigh Cyclical Slump Against Long-Ter
American Vanguard's stock is trading near its 52-week low, reflecting investor concerns over soft agricultural chemical demand and margin pressure. Despite a longer-term narrative around precision agriculture and environmental solutions, the stock has fallen about 40% in the last year. Wall Street analysts generally hold Neutral or Hold ratings, seeing potential upside if the agricultural cycle normalizes and management executes its strategic pivot, but remain cautious due to uncertainties.
American Vanguard Stock Tries To Find Its Footing As Investors Weigh Cyclical Slump Against Long-Ter
American Vanguard's stock (AVD) is trading near its 52-week low, reflecting investor concern over soft agricultural chemical demand and margin pressure. Despite a long-term narrative around precision agriculture and environmental solutions, the stock has fallen significantly, losing about 40% over the last year. The market remains in a "wait-and-see" mode, with analysts offering mixed "Neutral" or "Hold" ratings, suggesting a slow restructuring is underway.
American Vanguard (NYSE:AVD) Share Price Crosses Above Two Hundred Day Moving Average - What's Next?
American Vanguard (NYSE:AVD) shares recently crossed above their 200-day moving average, signaling a short-term bullish trend despite fundamental weaknesses. The company missed recent earnings estimates and has negative margins, with a consensus "Hold" rating from analysts. However, institutional investors are showing increased interest, with approximately 79% of the stock owned by institutions.
The Truth About American Vanguard Corp: Why Everyone Is Suddenly Watching This Sleeper Stock
American Vanguard Corp (AVD) is generating buzz as a "sleeper stock" due to its role in crop protection and specialty chemicals, a less glamorous but essential sector. While it's not a meme stock, finance commentators are noting its potential long-term upside for investors interested in real-economy plays tied to food security and agriculture. The article advises potential investors to focus on its fundamentals, risk profile, and market niche rather than expecting viral hype.
Brucite Market Is Going to Boom |• American Vanguard Corporation • U.S. Borax Inc.
The "Brucite Market" 2026 Research Report provides a comprehensive analysis of the global Brucite market, including development plans, policies, manufacturing processes, and price structures. It offers an analytical view of the industry by examining factors like market growth, consumption volume, market size, revenue, market share, trends, and cost structures from 2026 to 2033. The report also highlights key market players such as American Vanguard Corporation and U.S. Borax Inc., segmentation by types (industrial, agriculture, plastics, etc.) and applications (flame retardants, soil stabilization, etc.), and regional analysis across North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
The Truth About American Vanguard Corp: Why Everyone Is Suddenly Watching This Sleeper Stock
American Vanguard Corp (AVD) is gaining attention as a potential "sleeper stock" in the agricultural technology and crop protection sector. The article explores why this niche company, focused on essential products for farming, is attracting investors looking beyond typical meme stocks. It discusses AVD's business model, risk profile, and competitive landscape, concluding that it could be a valuable addition for long-term, fundamentals-driven investors comfortable with a less volatile, real-economy play.
American Vanguard Corp. (AVD) Slid Despite Clear Operational Improvement
Riverwater Partners' Micro Opportunities Strategy reported on American Vanguard Corporation (AVD) in its Q4 2025 investor letter, noting its underperformance despite operational improvements like reduced inventory, expanded gross margins, and improved adjusted EBITDA. The investment firm attributes AVD's stock price slide to market inefficiencies often seen in micro-cap equities and believes the company is on a path to a stronger operating profile, though its strategy focuses more on high-quality stocks. AVD's shares lost 15.35% over the last 52 weeks, closing at $4.3 per share on January 16, 2026, with a market cap of $122.413 million.
After losing 14% in the past year, American Vanguard Corporation (NYSE:AVD) institutional owners must be relieved by the recent gain
Institutional investors, holding 68% of American Vanguard Corporation (NYSE:AVD), are likely relieved by a recent 13% share price increase after a year of 14% losses. The top 18 shareholders collectively own 51% of the company, with BlackRock being the largest individual shareholder at 6.5%. Insiders own 1.0% of the company, valued at US$7.5 million, while the general public owns a 25% stake.
American Vanguard appoints DiPaola as chief commercial officer
American Vanguard Corporation announced the appointment of Mike DiPaola as Chief Commercial Officer, focusing on North American strategy. The company is also relocating its headquarters from Newport Beach to Irvine, California, by Q2 2026, as part of a cost-saving operational strategy. Despite its stock price decline over the past year, InvestingPro data suggests the stock is currently undervalued.
American Vanguard Trades At Bargain Levels As It Pursues A Turnaround
American Vanguard (NYSE: AVD) is an agrochemical company whose stock has significantly underperformed the S&P 500, dropping by 6.3% over the past year due to margin pressures and restructuring costs. Despite this, the company exhibits strong free cash flow and a management strategy focused on turnaround through inventory reduction, asset impairments, and a shift towards high-value biorational products. Analysts are bullish, with a consensus "Strong Buy" rating and a significant upside potential if the company successfully executes its strategic goals.
American Vanguard Corporation's (NYSE:AVD) Share Price Is Matching Sentiment Around Its Revenues
American Vanguard Corporation (NYSE:AVD) currently has a low price-to-sales (P/S) ratio of 0.2x, significantly below the Chemicals industry average of 1.1x in the United States. This low P/S ratio appears to be justified by the company's recent revenue performance, which has seen a decline of 4.3% last year and 13% over the past three years, contrasting with the industry's projected 5.4% expansion. Investors do not currently see enough potential for revenue improvement to warrant a higher P/S ratio.
At US$4.41, Is American Vanguard Corporation (NYSE:AVD) Worth Looking At Closely?
American Vanguard Corporation (NYSE:AVD) has seen significant price movements and is currently trading at US$4.41, which is below its estimated intrinsic value of $6.21, suggesting it might be undervalued. Although its short-term growth outlook is modest at 3.8% top-line growth, its high beta indicates potential for future buying opportunities during market downturns. The article suggests evaluating other factors like financial health and management before making investment decisions.
American Vanguard: Q3 Earnings Snapshot
American Vanguard Corp. (AVD) reported a third-quarter loss of $12.4 million, translating to a loss of 43 cents per share, or an adjusted loss of 18 cents per share. The agricultural products company generated $119.3 million in revenue during the period. The company's shares have risen 10% year-to-date but have declined 12% over the past 12 months.
American Vanguard Q3 2025 Earnings Call Transcript
American Vanguard reported its Q3 2025 earnings, with adjusted EBITDA rising to $8.2 million, a significant increase from the previous year. The company reaffirmed its full-year adjusted EBITDA target but trimmed its net sales forecast due to weaker demand in certain international markets. Management highlighted operational improvements, cost reductions, and a focus on debt reduction, while also expressing optimism about a strong product pipeline set to contribute to future sales.
American Vanguard (AVD) Earnings Transcript
American Vanguard (AVD) discussed various financial and operational aspects in its latest earnings transcript. The company reported reduced operating costs and a decrease in net debt, along with an extension of its credit facility. Management addressed product liability claims, US crop performance, and the future outlook, including potential acquisitions and a growing product pipeline.
Earnings call transcript: American Vanguard Q3 2025 results show mixed performance
American Vanguard (AVD) released its Q3 2025 earnings, showing a 1% revenue increase to $119 million and a significant 350% surge in adjusted EBITDA, despite missing EPS forecasts. The company improved gross profit margins to 29% and reduced operating costs, but its stock declined 7.06% pre-market. American Vanguard revised its full-year net sales forecast and anticipates normalized buying patterns and volume increases into 2026, driven by operational efficiencies and strategic growth initiatives.
American Vanguard: Q3 Earnings Snapshot
American Vanguard Corp. (AVD) reported a Q3 loss of $12.4 million, or 43 cents per share, with adjusted losses at 18 cents per share. The company posted revenue of $119.3 million for the period. American Vanguard shares have seen a 10% increase year-to-date, despite a 12% decline over the last 12 months.
